Jul 15, 2024 / 07:00AM GMT
Fredrik Dalborg - AddLife AB - President, Chief Executive Officer
Good morning, everyone, and welcome to the AddLife second quarter report. We will start with the presentation and then followed by a Q&A session. And after that, I strongly encourage you to stay on for a few more minutes to see a very good video describing the business we have in Eastern Europe, the Biomedica business. So let's get going and talk about the quarter.
In the second quarter, we had really good growth and continued profitability improvement. The growth was 8% or 7% currency adjusted and organic. EBITDA increased by 21%. And we're really starting to see profitability improvement initiatives starting to show clear results in the numbers. Really pleased to note the fact that both business areas are performing really well.
In the quarter, Labtech grew nicely. And you may remember in the last quarter that we had a bit of a weakness at the end, we were pretty confident that that was going to recover and it sure did. And the business also delivers stable margins. Medtech also grew really well. And here we see a
Half Year 2024 AddLife AB Earnings Call Transcript
Jul 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers